Antimycobacterial activity of Indigofera suffruticosa with activation potential of the innate immune system

Pharmaceutical Biology

Volumn 48, Issue 8, 2010, Pages 878-882

  De A Carli, Camila B ^a   Quilles, Marcela B ^a   Maia, Daniele C G ^a   Lopes, Flvia C M ^a   Santos Jr , Rubens ^a   Pavan, Fernando R ^a   Fujimura Leite, Clarice Q ^a   Calvo, Tamara R ^a   Vilegas, Wagner ^a   Carlos, Iracilda Z ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Antimycobacterial activity; Indigofera suffruticosa; Innate immune response

Indexed keywords

ANTIINFECTIVE AGENT; DICHLOROMETHANE; HYDROGEN PEROXIDE; INDIGOFERA SUFFRUTICOSA EXTRACT; ISONIAZID; METHANOL; NITRIC OXIDE; PLANT EXTRACT; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIBACTERIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; INDIGOFERA; INDIGOFERA SUFFRUTICOSA; INNATE IMMUNITY; MACROPHAGE ACTIVATION; MINIMUM INHIBITORY CONCENTRATION; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PERITONEAL EXUDATE CELL; PERITONEUM MACROPHAGE; TUBERCULOSIS;

ANIMALS; ANTI-BACTERIAL AGENTS; CELL SURVIVAL; CELLS, CULTURED; IMMUNITY, INNATE; INDIGOFERA; MICE; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; PLANT COMPONENTS, AERIAL; PLANT EXTRACTS;

FABACEAE; INDIGOFERA SUFFRUTICOSA; MYCOBACTERIUM TUBERCULOSIS;

EID: 77955178819     PISSN: 13880209     EISSN: 17445116     Source Type: Journal    
DOI: 10.3109/13880200903303471     Document Type: Article

References (37)

1. Adams LB, Mason CM, Kolls JK, Scollard D, Krahenbuhl JL, Nelson S (1995): Exacerbation of acute and chronic murine tuberculosis by administration of a tumor necrosis factor receptor-expressing adenovirus. J Infect Dis 171: 400-405.
2. Allavena P, Sica A, Solinas G, Porta C, Mantovani A (2008): The inflammatory micro-environment in tumor progression: the role of tumor-associated macrophages. CritRev OncolHematol 66: 1-9.
3. Akira N, Yuto U, Kunihiko T, Keisuke M (2002): Effect of tannin compounds on uranium-hydrogen peroxide system. Nippon Kagakkai Koen Yokoshu 81:634.
4. Babbar NRA, Casero J (2006): Tumor necrosis factor-alpha increases reactive oxygen species by inducing spermine oxidase in human lung epithelial cells: a potential mechanism for inflammation-induced carcinogenesis. Cancer Res 66: 11125-11130.
5. Bogdan C, Vodovotz Y, Nathan C (1991): Macrophage deactivation by interleukin 10. J Exp Med 174: 1549-1555.
6. Cantrell CL, Franzblau SG, Fischer NH (2001): Antimycobacterial plant terpenoids. Planta Med 67: 1-10.
7. Carli CBA, Matos DC, Lopes FCM, Maia DCG, Dias MB, Sannomiya M, Rodrigues CM, Andreo MA, Vilegas W, Colombo LL, Carlos IZ (2009): Isolated flavonoids against mammary tumour cells LM2. Z Naturforsch 64: 32-36.
8. 2 and NO response of peritoneal macrophages to Yersinia terocolitica O:3 derivatives. Microb Infect 6: 207-212.
9. Carlos IZ, Sgarbi DBG, Angluster J, Alviano CS, Silva CL (1994): Disturbances in the production of interleukin-1-necrosis and tumor necrosis factor in disseminated murine sporotrichosis. Mycopathologia 127: 189-194.
10. Collins LS, Franzblau SG (1997): Microplate alamar blue assay versus BACTEC 460 system for high-throughputscreening of compounds against Mycobacterium tuberculosis and Mycobacterium avium. Antimicrob Agents Chemother 41: 1004-1009.
11. Copp BR (2003): Antimycobacterial natural products. Nat Prod Rep 20: 535-557.
12. Ehlers S (2003): Role of tumour necrosis factor (TNF) in host defence against tuberculosis: implications for immu- notherapies targeting TNF. Ann Rheum Dis 62(Suppl. 2): ii37-ii42.
13. Flynn JL, Goldstein MM, Chan J, Triebold KJ, Pfeffer K, Lowenstein CJ, Schreiber R, Mak TW, Bloom BR (1995): Tumor necrosis factor-a is required in the protective immune response against M. tuberculosis in mice. Immunity 2: 561-572.
14. Gaemperli A, Hauser T, Speck RF (2006): Risk of infection during treatment with tumor necrosis factor-alpha inhibitors. Z Rheumatol 65: 24-31.
15. Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR (1982): Analysis of nitrate, nitrite, and [15N] nitrate in biological fluids. Anal Biochem 126: 131-138.
16. Gu JQ, Wang Y, Franzblau SG, Montenegro G, Yang D, Timmermann BN.Antitubercular constituents of Valeriana laxiflora. Planta Med 70: 509-514.
17. Hastings RB (1990): Medicinal legumes of Mexico: Fabaceae, Papilionoideae, Part One. Econ Bot 44: 336-348.
18. Higuchi CT, Pavan FR, Sannomiya M, Vilegas W, Leite SRA, Sacramento LVS, Sato DN, Leite CQF (2008a): Triterpenes and antitubercular activity of Byrsonima crassa. Quim Nova 31: 1719-1721.
19. Higuchi CT, Sannomiya M, Pavan FR, Leite SRA, Sato DN, Franzblau SG, Sacramento LVS, Vilegas W, Leite CQF (2008b): Byrsonima fagifolia Niedenzu a polar compound with anti- tubercular activity. Evid Based Complement Alternat Med 2008 Dec 17. [Epub ahead of print]
20. Keil DE, Luebke RW, Pruett BS (1999): Differences in the effects of dexamethasone on macrophage nitrite production: dependence on exposure regimem (in vivo or in vitro) and activation stimuli. Int J Immunopharmacol 17: 157-166.
21. Kwon OJ (1997): The role of nitric oxide in the immune response of tuberculosis. Korean Med Sci 12: 481-487.
22. Leite SP, Vieira JRC, de Medeiros PL, Leite RMP, Lima VLM, Xavier HS, Lima ED (2006): Antimicrobial activity of Indigofera suffruticosa. eCAM 3: 261-265.
23. Lopes FCM, Benzatti FP, Jordao Junior CM, Moreira RRD, Carlos IZ:Effect of the essential oil of Achillea millefolium L. in the production of hydrogen peroxide and tumor necrosis factor-a in murine macrophages.Braz J Pharm Sci 41:401-405
24. McKinney JD (2000): In vivo veritas: the search for TB drug targets goes live. Nat Med 6: 1330-1333.
25. Mosmann T (1983): Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65: 55-63.
26. NAPRALERT (2003): Natural Products Alert, Illinois University, Chicago. Available at: NAPRALERT.htm. Accessed 15 July 2009.
27. Nathan C, Shiloh MU (2000): Reactive oxygen and nitrogen intermediates in the relationship between mammalian hosts and microbial pathogens. Proc Natl Acad Sci USA 97: 8841-8848.
28. Okunade AL, Elvin-Lewis MP, Lewis WH (2004): Natural antimycobac- terial metabolites: current status. Phytochemistry 65: 1017-1032.
29. Paiva MAS, Barbosa ACD, Alves HLJB (1987): Indigofera suffruticosa Mill (Leguminosae) com potencial forrageiro em uma regiao de Caatinga no Semi-arido de Pernambuco (Alagoinha). In: Proceedings of the XXXVIII Congresso Nacional de Botanica. Sao Paulo, Brasil: Sociedade Nacional de Botanica, p. 422.
30. Palladino MA, Bahjat FR, Theodorakis EA, Moldawer LL (2003): Anti-TNF-a therapies: the next generation. Nat Rev Drug Discov 2: 736-746.
31. Pavan FR, Leite CQF, Coelho RG, Coutinho ID, Honda NK, Cardoso CAL, Vilegas W, Leite SRA, Sato DN (2009): Evaluation of anti-Mycobacterium tuberculosis activity of Campomanesia adamantium (MYRTACEAE). Quim Nova 32: 1222-1227.
32. Pick E, Mizel DJ (1981): Superoxide anion and hydrogen peroxide production by chemically elicited peritoneal macrophages induction by multiple nonphagocytic stimuli. J Immunol Methods 46: 211-226.
33. Raupach B, Kaufmann SHE (2001): Immune responses to intracellular bacteria. Curr Opin Immunol 13: 417-428.
34. Walker L, Lowrie DB (1981): Killing of Mycobacterium microti by immunologically activated macrophages. Nature 293: 69-70.
35. WHO (2008): Available at: global-report/2008/chapter-1/en/index3.html. Accessed 3 December 2008.
36. Yang C, Yuk J, Jo E (2009): The role of nitric oxide in mycobacterial infections. Immune Netw 9: 46-52.
37. Yee D, Valiquette C, Pelletier M, Parisien I, Rocher I, Menzies D (2003): Incidence of serious side effects from first-line antituberculosis drugs among patients treated for active tuberculosis. Am J Respir Crit Care Med 167: 1472-1477.